PAVmed (PAVM) Price to Sales (2021 - 2026)

PAVmed has reported Price to Sales for 6 years, with the latest figure at 4212.52 in Q2 2026.

• On a quarterly basis, Price to Sales fell 93.03% year-over-year to 4212.52 in Q2 2026; TTM through Jun 2026 was 1112.11, a 207.65% increase from a year earlier, with the FY2025 full-year figure at 44.45, down 62.92% from the prior year.
• Price to Sales was 4212.52 for Q2 2026 at PAVmed, up from 54.88 in the prior quarter.
• The five-year high for Price to Sales was 60427.39 in Q2 2025, with the low at 54.88 in Q4 2025.
• Average Price to Sales over 5 years is 19405.98, with a median of 8003.44 recorded in 2023.
• The largest YoY upside for Price to Sales was 12595.03% in 2025 against a maximum downside of 99.85% in 2025.
• Over 5 years, Price to Sales stood at 12151.96 in 2022, then sank by 81.52% to 2245.68 in 2023, then surged by 1498.96% to 35907.47 in 2024, then tumbled by 99.85% to 54.88 in 2025, then soared by 7576.03% to 4212.52 in 2026.
• The last three Price to Sales figures came in at 4212.52 (Q2 2026), 54.88 (Q4 2025), and 59616.35 (Q3 2025), per Business Quant data.